COMPOUND AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITOR FOR TREATING PLATELET AGGREGATION

Title:

COMPOUND AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITOR FOR TREATING PLATELET AGGREGATION

Document Type and Number:

WIPO Patent Application WO/2019/218955

Kind Code:

A1

Abstract:

Provided is a series of compounds used as protease inhibitory receptor 4 (PAR4) inhibitors for treating platelet aggregation and medical use thereof, relating to the technical field of chemical medicines.

Inventors:

WU JUNJUN (CN)
LI SHUO (CN)
WEN XIAOMING (CN)
YANG HUA (CN)
WEI GUOPING (CN)
HU YUNJIN (CN)
QIAN SU (CN)

Application Number:

PCT/CN2019/086556

Publication Date:

November 21, 2019

Filing Date:

May 13, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SHENZHEN SALUBRIS PHARM CO LTD (CN)

International Classes:

C07D519/00; A61K31/433; A61P7/02

Foreign References:

CN104540835A	2015-04-22
CN104640869A	2015-05-20

Download PDF:

View/Download PDF PDF Help

Previous Patent: PIXEL CIRCUIT, DRIVING METHOD AND DEVICE THEREFOR, ARRAY SUBSTRATE AND DISPLAY DEVICE

Next Patent: COMPOUND ACTING AS PROTEASE-ACTIVATED RECEPTOR 4 (PAR4) INHIBITOR FOR TREATING PLATELET AGGREGATION